IN8bio Inc
NASDAQ:INAB
IN8bio Inc Stock, NASDAQ:INAB
350 5th Avenue, Suite 5330, New York, New York 10118
United States of America
Phone: +1.646.600.6438
Number of Employees: 19
Description
IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. Lamb and William T. Ho on February 8, 2016 and is headquartered in New York, NY.